Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

How cost-effective are sirolimus-eluting stents when compared with bare-metal stents?

Nature Clinical Practice Cardiovascular Medicine volume 2, pages 512–513 (2005)Cite this article

boxed-textvan Hout BA et al. (2005) One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial. Heart 91: 507–512

The extra cost of sirolimus-eluting stents is almost balanced at 1 year by the cost reduction due to fewer revascularizations; however, economic analyses from other randomized trials and real-world data are needed before routine use

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Moses JW et al.; SIRIUS Investigators (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349: 1315–1323

    Article  CAS  Google Scholar 

  2. Schofer J et al. (2003) Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 362: 1093–1099

    Article  CAS  Google Scholar 

  3. Schampaert E et al. (2004) The Canadian Study of the Sirolimus-Eluting Stent in the Treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 43: 1110–1115

    Article  CAS  Google Scholar 

  4. Stone GW et al. (2004) One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 109: 1942–1947

    Article  CAS  Google Scholar 

  5. Cohen DJ et al. on behalf of the SIRIUS Investigators (2004) Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation 110: 508–514

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. an Interventional Cardiologist at the Department of Interventional Cardiology at the Hospital Clínico San Carlos, Madrid, Spain

    Raúl Moreno

Authors
  1. Raúl Moreno
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raúl Moreno.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moreno, R. How cost-effective are sirolimus-eluting stents when compared with bare-metal stents?. Nat Rev Cardiol 2, 512–513 (2005). https://doi.org/10.1038/ncpcardio0327

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0327

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing